Table 2 Type distribution of high-risk HPV genotypes in cancerous and benign prostate tissues. The HPV positivity rate was 32.7% (18.4–49.6%, 95% bootstrap CI) using the bootstrapping assay for the table.
From: Detection of high-risk Human Papillomavirus in prostate cancer from a UK based population
Pathological status | HPV genotype | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HPV + cancerous cases n = 5 5/14 (36%) | 16 | 31 | 33 | 35 | 18 | 39 | 45 | 59 | 52 | 56 | 58 | 66 |
2/5 (40) | – | – | 2/5 (40) | – | 1/5 (20) | – | – | 1/5 (20) | 2/5 (40) | 1/5 (20) | – | |
HPV + benign cases n = 11 11/35 (31%) | 16 | 31 | 33 | 35 | 18 | 39 | 45 | 59 | 52 | 56 | 58 | 66 |
Prostatitis 9/23 (39%) | 1/9 (11) | – | 3/9 (33) | 3/9 (33) | – | – | 1/9 (11) | – | 4/9 (44) | 1/9 (11) | 1/9 (11) | – |
No prostatitis 2/12 (17%) | – | – | 1/2 (50) | 2/2 (100) | – | – | – | – | – | – | – | – |
Total prevalence of specific HPV genotype cases n = | 1/11 (9) | – | 4/11 (36) | 5/11 (45) | – | – | 1/11 (9) | – | 4/11 (36) | 1/11 (9) | 1/11 (9) | – |
